Uroonkologie pp 275-359 | Cite as

Hodentumoren

  • L. Weißbach
  • R. Bussar-Maatz

Zusammenfassung

In Europa befassen sich außerhalb der verschiedenen nationalen Krebsorganisationen einige Studiengruppen speziell mit dem Hodentumor: die Genitourinary Group (GU-Group) der EORTC (European Organization for Research an the Treatment of Cancer), das MRC (Medical Research Council) in Großbritannien, die DATECA in Dänemark, die SWENOTECA in Schweden und Norwegen, das Institut Gustave Roussy (IGR) in Villejuif/Frankreich. In Deutschland arbeiten Urologen, internistische Onkologen und Radiologen in der „Interdisziplinären Arbeitsgruppe Hodentumoren“ mit dem Ziel, möglichst viele Tumoren in gemeinsam abgestimmten Protokollen zu behandeln, so daß die aktuellen Fragen zur Therapie beantwortet werden können.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Ahlgren P, Langleben A, Fauser A, Shustik C (1988) Autologous bone marrow transplantation as primary therapy for poor prognosis germ cell cancer. Proc Am Soc Clin Oncol 133:No 514Google Scholar
  2. Aiginger P, Kuzmits R, Kratzik C, Schwarz HP, Zielinski CC, Kühböck J, Mayr WR (1987) HLA antigens and germ-cell tumours. Lancet II: 276–277Google Scholar
  3. Allhoff E, Wittekind C, Liedke S, Tanke H, Jonas U (1990) Der Modular Image Analysis Computer in der Prognoseerfassung bei Hodentumoren. Verh Dtsch Ges Pathol 74: 196–198PubMedGoogle Scholar
  4. Allhoff EP, Liedke S, de Riese W et al. (1991) Assessment of individual prognosis for patients with NSGCT/CS I. J Urol 145:Abstract No. 617Google Scholar
  5. Al-Naieb MG, Kleinschmidt K, Schülke J, Wolters A (1988) Skrotale Sonographie. In: Weißbach L, Bussar-Maatz R (Hrsg) Die Diagnostik des Hodentumors und seiner Metastasen. Ergebnisse einer TNM-Validierungsstudie. Karger, Basel, S 37–57Google Scholar
  6. Amelar RD, Dubin L (1977) Other factors affecting male infertility. In: Amelar RD, Dubin L, Walsh (eds) Male infertility. pp 73–75Google Scholar
  7. Athanassiou A, Pectasides D, Bourazanis J, Barbounis V, Moutzourides G, Marasionis N (1991) BEC/ACOB chemotherapy in testicular cancer. ECCO 6 Eur J Cancer Suppl 2:No 652Google Scholar
  8. Bach DW, Weißbach L, Hartlapp JH (1983) Bilateral testicular tumors. J Urol 29: 989Google Scholar
  9. Bajorin DF, Geller NL, Weisen StF, Bosl GJ (1991) Two-drug therapy in patients with metastatic germ cell tumors. Cancer 67: 28–32PubMedCrossRefGoogle Scholar
  10. Ball D, Barrett A, Peckham MJ (1982) The management of metastic seminoma testis. Cancer 50: 2289–2294PubMedCrossRefGoogle Scholar
  11. Bamberg M, Wannenmacher H, Behrendt H (1991) Multizentrische prospektive Studie zur Radiotherapie bei Seminomen in den klinischen Stadien I, IIA und IIB. Studienprotokoll, TübingenGoogle Scholar
  12. Bannwart F, Maurer R, Hedinger C (1991) Carcinoma in situ of the testis. Histopathology 18: 189–192PubMedCrossRefGoogle Scholar
  13. Barnett MJ, Coppin CML, Murray N et al. (1991) Intensive therapy and autologous bone marrow transplantation for patients with poor prognosis nonseminomatous germ cell tumors. Proc Am Soc Clin Oncol 10:No 524Google Scholar
  14. Bartsch G, Mikuz G, Frommhold H, Scheiber K (1985) Treatment of seminoma: Does a positive HCG influence prognosis? In: Khoury S, Küss R, Murphy GP, Chatelain C, Karr JP (eds) Testicular cancer. Liss, New York, S 483–484Google Scholar
  15. Belldegrun A, Garnick MB, Klein LA, Richie JP (1984) The management of primary bilateral germ cell testicular tumors. J Urol 131: 226AGoogle Scholar
  16. Berndt H, Berndt R (1982) Inzidenz und Mortalität an bösartigen Neubildungen der Harnorgane und männlichen Geschlechtsorganen in der DDR. Urologe [A] 21: 185–189Google Scholar
  17. Biron P, Brunat-Mentigny M et al. (1989) Cisplatinum — VP-16 and ifosfamide + autologous bone marrow transplantation, in poor prognostic nonseminomatous germ cell tumors. Proc Am Soc Oncol 8:148 No 576Google Scholar
  18. Birch R, Williams S, Cone A, Einhorn L, Roark P, Turner S, Greco FA (1986) Prognostic factors for favorable outcome in disseminated germ cell tumors. J Clin Oncol 4: 400–407PubMedGoogle Scholar
  19. Bissett D, Kunkeler L, Zwanenburg L et al. (1990) Long-term sequelae of treatment for testicular germ cell tumours. Br J Cancer 62: 655–659PubMedCrossRefGoogle Scholar
  20. Boden G, Gibb R (1951) Radiotherapy and testicular neoplasma. Lancet II: 1195–1197Google Scholar
  21. Bokemeyer C, Schmoll A, Harstrick A et al (1991) Dose intensified treatment for advanced germ cell cancer with cisplatin, etoposide and ifosfamide plus GM-CSF. ECCO 6 Eur J Cancer, Suppl 2:No 641Google Scholar
  22. Borchers H, Sohn M, Müller-Leisse C, Fischer N, Jakse G (1991) Growing teratoma syndrome. Onkologie 14 [Suppl 4]: 13Google Scholar
  23. Bosl GJ, Geller NL, Cirrincione C at al. (1983) Multivariate analysis of prognostic variables in patients with metastatic testicular cancer. Cancer Res 43: 3403–3407Google Scholar
  24. Bosl GJ, Bajorin D, Geller NL (1987) An analysis of poor risk assignment in patients with germ cell tumours. Int J Androl 10: 285–289PubMedCrossRefGoogle Scholar
  25. Bosl GJ, Geller NL, Penenberg D, Golbey R (1988) A comparison of the Memorial Hospital and Einhorn classifications of germ cell tumor patients. Proc Am Soc Clin Oncol 7:121 No 468Google Scholar
  26. Bracken RB, Johnson DE (1976) Sexual function and fecundity after treatment for testicular tumors. Urology 7: 35–38PubMedCrossRefGoogle Scholar
  27. Brenner J, Vugrin D, Whitmore WF Jr (1983) Effect of treatment on fertility and sexual function in males with non seminomatous germ cell tumors of the testis. (Abstract C-565) Proc Am Soc Clin Oncol 2: 44Google Scholar
  28. Brooks ME, Berezin M, Braf Z (1980) Treatment of retrograde ejaculation with imipramine. Urology 15: 353PubMedCrossRefGoogle Scholar
  29. Burke AP, Mostofi FK (1988) Placental alkaline phosphatase immunohistochemistry of intratubular malignant germ cells and associated testicular germ cell tumors. Hum Pathol 19: 663–670PubMedCrossRefGoogle Scholar
  30. Bussar-Maatz R, Weißbach L (1988) Beziehungen zwischen Primärtumor and Metastasierung. In: Weißbach L, Bussar-Maatz R (Hrsg) Die Diagnostik des Hodentumors and seiner Metastasen. Ergebnisse einer TNM-Validierungsstudie. Karger, Basel, S 170–177Google Scholar
  31. Bussar-Maatz R, Weißbach L for the TNM Study-Group (im Druck) Retroperitoneal lymph node stagig of testicular tumors with special consideration of surveillance in clinical stage I and primary chemotherapy in clinical stage II. — Results of a prospective multicenter study (in Druck)Google Scholar
  32. Butcher DN, Gregory WM, Gunter PA, Masters JRW, Parkinson MC (1985) The biological and clinical significance of HCG-containing cells in seminoma. Br J Cancer 51: 473–478PubMedCrossRefGoogle Scholar
  33. Cavalli F Monfardini S, Pizzocaro G (1980) Report on the international workshop on staging and treatment of testicular cancer. Eur J Cancer 16: 1367–1372PubMedGoogle Scholar
  34. Chiappa S, Uslenghi C, Galli G, Ravasi G, Bonadonna G (1966) Lymphangiography and endolymphatic radiotherapy in testicular tumours. Br J Radiol 39: 498–512PubMedCrossRefGoogle Scholar
  35. Chiou RK, Fraley EE, Lange PH (1984) Newer ideas about fertility in patients with testicular cancer. World J Urol 2: 26–31CrossRefGoogle Scholar
  36. Clemm C et al. (1987) Intensified chemotherapy with a four-drug regimen for nonsemino- matous germ cell tumor (NSGCT) and large tumor burden. Proc ECCO 4, 700: 184Google Scholar
  37. Clemm C, Hartenstein R, Willich N, Heim M, Wagner M, Williams W (1988) VIP-Chemotherapie beim Seminom mit großer Tumormasse. In: Schmoll HJ, Weißbach L (Hrsg) Diagnostik and Therapie von Hodentumoren. Springer, Berlin Heidelberg New York Tokyo, S 461–467CrossRefGoogle Scholar
  38. Clemm C, Sauer H, Schilling S, Binsack T, Willmanns W (1991) Rehabilitation von Patienten mit malignem Keimzelltumor. Versicherungsmed 43: 105Google Scholar
  39. Coffin CM, Ewing S, Dehner LP (1985) Frequency of intratubular germ cell neoplasia with invasive testicular germ cell tumors. Arch Pathol Lab Med 109: 555–559PubMedGoogle Scholar
  40. Colleselli K, Poisel S, Schachtner W et al. (1990) Nerve-preserving bilateral retroperitoneal lymphadenectomy: anatomical study and operative approach. J Urol 144: 293–298PubMedGoogle Scholar
  41. Coscojuela P, Llauger J, Perez C, Germa J, Castaner E (1991) The growing teratoma syndrome: radiologic findings in 4 cases. Eur J Radiol 12: 138–140PubMedCrossRefGoogle Scholar
  42. Costello AJ, Mortensen PH, Stillwell RG (1989) Prognostic indicators for failure of surveillance management of stage I non-seminomatous germ cell tumours. Aust NZ J Surg 59: 119–122CrossRefGoogle Scholar
  43. Cramer BM, Schlegel E, Thüroff JW (1989) Klinische Wertigkeit der MRT bei Erkrankungen der Hoden und des Scrotums. Radiol Diagn 30: 391–399Google Scholar
  44. Crawford SM, Rustin GJS, Begent RHJ, Newlands ES, Bagshawe KD (1986) Detection of relapse in Stage I testicular germ cell tumours. In: Jones WG, Milford Ward A, Anderson CK (ed) Germ cell tumours II. Pergamon, Oxford, pp 452Google Scholar
  45. Cullen MH, Harper PG, Woodroffe CM et al. (1988) Chemotherapy of poor risk germ cell tumours. An independent evaluation of POMB/ACE regime. Br J Urol 62: 454–60PubMedCrossRefGoogle Scholar
  46. Dahlmann N, Hartlapp JH (1989) Chemotherapy of a patient because of spuriously elevated alpha-fetoprotein levels. Klin Wochenschr 67: 408–412PubMedCrossRefGoogle Scholar
  47. Daugaard G, Hansen HH, Rorth M (1987) Management of advanced metastatic germ cell tumours. Int J Androl 10: 319–324PubMedCrossRefGoogle Scholar
  48. Dearnaley DP (1991) Intensive induction treatment for poor risk patients. In: Horwich A (ed) Testicular cancer; investigation and management. Chapman, and Hall Medical, London, p 233Google Scholar
  49. Depue RH, Pike MC, Henderson BE (1983) Estrogen exposure during gestation and risk of testicular cancer. J Natl Cancer Inst 71: 1151–1155PubMedGoogle Scholar
  50. Dewar 1M, Spagnolo DV, Jamrozik KD, Hazel GA van, Byrne MJ (1987) Predictingre lapse in stage I non-seminomatous germ cell tumours of the testis. Lancet II: 454Google Scholar
  51. DeWolf WC (1987) Somatic deletion of chromosome 6 DNA in human teratocarcinoma. J Urol 137:213 AGoogle Scholar
  52. Dexeus FH, Logothetis CJ, Chong C, Sella A, Ogden S (1988) Genetic abnormalities in men with germ cell tumors. J Urol 140: 80–84PubMedGoogle Scholar
  53. Dieckmann KP (1991 a) Diagnostik und Therapie der Testikulären Intraepithelialen Neoplasie. Onkologie 14 [Suppl 4]:6Google Scholar
  54. Dieckmann KP ( 1991 b) Pathogenese und Frühdiagnostik der germinalen Hodentumoren. Habilitationsschrift, BerlinGoogle Scholar
  55. Dieckmann KP, Boeckmann W, Brosig W, Jonas D, Bauer HW (1986) Bilateral testicular germ cell tumors. Cancer 57: 1254PubMedCrossRefGoogle Scholar
  56. Dieckmann KP, Becker T, Jonas D, Bauer HW (1987 a) Inheritance and testicular cancer. Arguments based on a report of 3 cases and a review of the literature. Oncology 44: 367–377Google Scholar
  57. Dieckmann KP Becker T, Jonas D, Bauer HW ( 1987 b) Testikuläre Tumoren: Bedeutung der Anamnesedauer und des pT-Stadiums. Verh Ber Dtsch Ges Urol, Springer, Berlin Heidelberg New York Tokyo, S 365–366Google Scholar
  58. Dieckmann KP, Keyserlingk H von, Becker T, Bauer HW (1988) HLA-Typisierung beim Seminom. Ein Argument für die Wirksamkeit genetischer Faktoren in der Pathogenese der Keimzelltumoren. Verh Ber Dtsch Ges Urol, Springer, Berlin Heidelberg New York, S 228–229Google Scholar
  59. Dieckmann KP, Loy V Huland H (1989) Das Carcinoma in situ des Hodens: Klinische Bedeutung, Diagnostik und Therapie. Urologe [A] 28: 271–280Google Scholar
  60. Donohue JP (1983) Transabdominal Lymphadenectomy. In: Donohue JP (Ed) Testis Tumors. Williams, and Wilkins Baltimore, pp 178–206Google Scholar
  61. Donohue JP (1987) Management of low clinical stage testis cancer. Editorial comment. Urol Clin North Am 14, 729–730Google Scholar
  62. Donohue JP (1990) Nerve-sparing retroperitoneal lymphadenectomy. In: Jaeger N, Hartlapp JH (Hrsg) Aktueller Stand der Diagnostik und Therapie von Hodentumoren. Karger, Basel, S 195–204Google Scholar
  63. Donohue JP (1991) The Indiana University experience with salvage chemotherapy. Symposium der Interdisziplinären Arbeitsgemeinschaft Hodentumoren: Neue Aspekte in der Therapie von Hodentumoren, Hannover. Onkologie 14, supp14: 15Google Scholar
  64. Donohue JP, Zachary JM, Maynard BR (1982) Distribution of nodal metastases in nonseminomatous testis cancer. J Urol 128: 315–319PubMedGoogle Scholar
  65. Donohue JP, Rowland RG, Kopecky K (1987) Correlation of computerized tomographic changes and histological findings in 80 patients having radical retroperitoneal lymph node dissection after chemotherapy for testis cancer. J Urol 137: 1176–1179PubMedGoogle Scholar
  66. Donohue JP, Foster RS, Geier G, Rowland RG, Bihrle R (1988) Preservation of ejaculation following nerve-sparing retroperitoneal lymphadenectomy. J Urol 139: 206Google Scholar
  67. Doornbos JF, Hussey DH, Johnson DE (1975) Radiotherapy for pure seminoma of the testis. Radiology 116: 401–404PubMedGoogle Scholar
  68. Dosoretz D, Shipley W, Bitzer P et al. (1981) Megavoltage irradiation for pure testicular seminoma: Results and patterns of failure. Cancer 48: 2184–2190Google Scholar
  69. Drasga EE, Einhorn LH, Williams SD et al. (1983) Fertility after chemotherapy for testicular cancer. J Clin Oncol 1: 179–183PubMedGoogle Scholar
  70. Droz JP (1988) High dose chemotherapy for testicular cancer. Intern Meeting at UCLA, Mai 1988Google Scholar
  71. Droz JP, Kramar A, Ghosn M et al. (1988) Prognostic factors in advanced nonseminomatous testicular cancer. Cancer 62: 564–568PubMedCrossRefGoogle Scholar
  72. Droz JP, Pico JL, Ghosn M et al. (1989 a) High complete remission and survival rates in poor prognosis non seminomatous germ cell tumors with high dose chemotherapy and autologous bone marrow transplantation. Proc Am Soc Clin Oncol 8, 505: 130Google Scholar
  73. Droz JP, Pico JL, Ghosn M et al. (1989 b) High survival rate in poor prognostic testicular cancer with massive chemotherapy. Proc ECCO 5:No 0–0792Google Scholar
  74. Droz JP, Kramar A, Rey A (1992) Prognostic factors in metastatic disease. Semin Oncol 19: 181–189PubMedGoogle Scholar
  75. Duchesne GM, Horwich A, Dearnaley DP, Nicholls J, Peckham MJ (1990) Orchidectomy alone for stage I seminoma of the testis. Cancer 65: 1115–1118PubMedCrossRefGoogle Scholar
  76. Duncan W, Munro AJ (1987) The management of testicular seminoma. Edinburgh 1970–1981. Br J Cancer 55: 443–448PubMedCrossRefGoogle Scholar
  77. Einhorn LH (1990) Treatment of testicular cancer: a new and improved model. J Clin Oncol 8: 1777–1781PubMedGoogle Scholar
  78. Einhorn LH, Donohue JP (1977) Cis-diaminedichloroplatinum, vinblastine, bleomycin combination chemotherapy in disseminated testicular cancer. Ann Intern Med 87: 293–298PubMedCrossRefGoogle Scholar
  79. Einhorn LH, Williams SD (1980) Chemotherapy of disseminated testicular cancer. Cancer 46: 1339–1344PubMedCrossRefGoogle Scholar
  80. Einhorn L, Donohue JP, Peckham MJ et al. (1985) Cancer of the testes. In: de Vita VT Hellmann S, Rosenberg SA (eds) Cancer principles and practice of oncology. JB Lippincott, Philadelphia. p 979–1011Google Scholar
  81. Einhorn LH, Williams S, Loehrer P, Birch R, Greco FA (1988) A cômparison of four courses of cisplatin, VP 16 and bleomycin in favorable prognosis disseminated germ cell tumors: a Southeastern Cancer Study Group protocol. Proc Am Soc Clin Oncol 7: 120 No 462Google Scholar
  82. Escher F (1980) Therapiebedingte Risiken für die Nachkommenschaft von Männern mit malignen Hodentumoren. Inaugural-Dissertation BonnGoogle Scholar
  83. Forman D, Gallagher R, Moller H et al. (1990) Aetiology and epidemiology of testicular cancer: report of consensus group. In: Newling DWW and Jones WG (Hrsg) Prostate cancer and testicular cancer. Wiley-Liss Inc., New York, S 245–253Google Scholar
  84. Fossa SD, Risberg T (1985) b-HCG-producing seminoma. In: Khoury S, Küss R, Murphy GP, Chatelain C, Karr JP (eds) Testicular cancer. Liss, New York, p 105Google Scholar
  85. Fossa SD, Ous S, Abyholm T, Loeb M ( 1985 a) Post-treatment fertility in patients with testicular cancer. I. Influence of retroperitoneal lymph node dissection on ejaculatory potency. Br J Urol 57: 204–209Google Scholar
  86. Fossa SD, Ous S, Abyholm T et al. ( 1985 b) Post-treatment fertility in patients with testicular cancer. II. Influence of cis-platin-based combination chemotherapy and of retroperitoneal surgery on hormone and sperm cell production. Br J Urol 57: 210–214Google Scholar
  87. Fossa SD, Almaas B, Jetne V et al. (1986) Paternity after irradiation for testicular cancer. Acta Radiol Oncol 25 (Fasc. 1): 33–36PubMedCrossRefGoogle Scholar
  88. Fossa SD, Borge L, Aass N et al. (1987) The treatment of advanced metastatic seminoma: Experience in 55 cases. J Clin Oncol 5: 1071–1077PubMedGoogle Scholar
  89. Fossa SD, Ous S, Lien HH, Stenwig AE (1989 a) Post-chemotherapy node histology in radiologically normal patients with metastatic nonseminomatous testicular cancer. J Urol 141: 557Google Scholar
  90. Fossa SD, Aass N, Ous S et al. (1989 b) Histology of tumor residuals following chemotherapy in patients with advanced nonseminomatous testicular cancer. J Urol 142: 1239–1242Google Scholar
  91. Fossa SD, Aass N, Kaalhus 0 (1989 c) Long-term morbidity after infradiaphragmatic radiotherapy in young men with testicular cancer. Cancer 64: 404–408Google Scholar
  92. Fossa SD, Langmark F, Aass N, Andersen A, Lothe R, Borresen AL (1990) Second non-germ cell malignancies after radiotherapy of testicular cancer with or without chemotherapy. Br J Cancer 61: 639–643PubMedCrossRefGoogle Scholar
  93. Fossa SD, Langmark F Aass N et al. (1990) Second non-germ cell malignancies after radiotherapy of testicular cancer with or without chemotherapy. Br J Cancer 61: 639–643PubMedCrossRefGoogle Scholar
  94. Fossa SD, Melvik JE, Juul NO, Pettersen EO, Amellem O, Theodorsen L (1991) DNA flow cytometry in sperm cells from testicular cancer patients. Eur Urol 19: 125–131PubMedGoogle Scholar
  95. Fraley EE, Lange PH (1984) Technical nuances of extended retroperitoneal dissection for low-stage nonseminomatous testicular germ-cell cancer. World J Urol 2: 43–47CrossRefGoogle Scholar
  96. Freedman LS, Parkinson MC, Jones WG et al (1987) Histopathology in the prediction of relapse of patients with stage I testicular teratoma treated by orchidectomy alone. Lancet II: 294–298Google Scholar
  97. Freiha FS, Shortliffe LD, Picozzi VJ, Torti FM, Alto P (1985) Stage I non-seminomatous testis tumors: is retroperitoneal lymph node dissection always necessary? J Urol 133: 244AGoogle Scholar
  98. Fried P, Steinfeld R, Casileth B et al. (1987) Incidence of developmental handicaps among the offspring of men treated for testicular seminoma. In: Rorth M, Daugaard G, Skakkebaek NE, Grigor KM, Giwercman A (eds): Carcinoma in situ and cancer of the testis. Blackwell Scientific Publ Oxford p 385–387Google Scholar
  99. Friedman EL, Garnick MB, Stomper PC et al. (1985) Therapeutic guidelines and results in advanced seminoma. J Clin Oncol 3: 1325–1332PubMedGoogle Scholar
  100. Fung CY, Kalish LA, Brodsky GL, Richie JP, Garnick MB (1988) Stage I nonseminomatous germ cell testicular tumor: prediction of metastatic potential by primary histopathology. J Clin Oncol 6: 1467–1473PubMedGoogle Scholar
  101. Gelderman WAH, Schraffordt Koops H et al (1987) Orchidectomy alone in stage I nonseminomatous testicular germ cell tumors. Cancer 59: 578PubMedCrossRefGoogle Scholar
  102. Geier LJ, Volk SA, Weldon D et al. (1983) Late relapse in testicular cancer after chemotherapy. Lancet II: 1049Google Scholar
  103. Giwercman A, Marks A, Skakkebaek NE (1988) Carcinoma-in-situ germ-cells exfoliated from seminiferous epithelium into seminal fluid. Lancet II: 530Google Scholar
  104. Glanzmann C, Schultz A, Lütolf UM (1989) Long-term toxicity of adjuvant irradiation in 386 patients with testicular cancer. Proc ECCO 5:No P-0800Google Scholar
  105. Glanzmann CH, Schultz G, Lütolf UM (1991) Long-term morbidity of adjuvant infra-diaphragmatic irradiation in patients with testicular cancer and implications for the treatment of stage I seminoma. Radiother Oncol 22: 12–18PubMedCrossRefGoogle Scholar
  106. Gonnermann D (1991) Primäre Chemotherapie beim Nichtseminon im Stadium I. Onkologie 14 [Suppl 4]: 14Google Scholar
  107. Greiner R (1982) Die Erholung der Spermatogenese nach fraktionierter, niedrig dosierter Bestrahlung der männlichen Gonaden. Strahlentherapie 158: 342PubMedGoogle Scholar
  108. Greiner R (1985) Wirkung der Strahlen-and Chemotherapie auf die Gonadenfunktion. Munch Med Wochenschr 127: 870–874Google Scholar
  109. Greiner R, Meyer A (1977) Reversible and irreversible Azoospermie nach Bestrahlung des malignen Hodentumors. Strahlentherapie 153: 257–262PubMedGoogle Scholar
  110. Greist A, Roth B, Einhorn L et al. (1985) Cisplatin-combination chemotherapy for disseminated germ cell tumors: Long term follow-up. Proc Am Soc Clin Oncol 4, Abstr. C-388Google Scholar
  111. Grigor KM, Dettre SI, Kohn J, Neville AM (1977) Serum alphal-foetoprotein levels in 153 male patients with germ cell tumours. Br J Cancer 35: 52–58PubMedCrossRefGoogle Scholar
  112. Hainsworth JD, Greco FA (1983) Testicular germ cell neoplasms. Am J Med 75: 817–832PubMedCrossRefGoogle Scholar
  113. Hamilton C, Horwich A, Easton D et al. (1986) Radiotherapy for stage I seminoma testis: Results of treatment and complications. Radiother Oncol 6: 115–120Google Scholar
  114. Hansen PV, Trykker H, Helkjaer PE, Andersen J (1989) Testicular function in patients with testicular cancer treated with orchiectomy alone or orchiectomy plus cisplatinbased chemotherapy. J Natl Cancer Inst 81: 1246–1250PubMedCrossRefGoogle Scholar
  115. Harstrick A, Schmoll HJ, Wilke H, Casper J (1990) Epidemiologie von Hodentumoren. In: Jaeger N, Hartlapp JH (Hrsg) Aktueller Stand der Diagnostik and Therapie von Hodentumoren. Karger, Basel, S 1–8Google Scholar
  116. Hartlapp JH, Weißbach L (1988) Therapie nichtseminomatöser Hodentumoren im Stadium IIAB: Lymphadenektomie +/- adjuvante Chemotherapie vs. primäre Chemotherapie. In: Schmoll HJ, Weißbach L (Hrsg) Diagnostik and Therapie von Hodentumoren. Springer-Verlag Berlin Heidelberg New York, S 179–187Google Scholar
  117. Hay JH, Duncan W, Kerr GR (1984) Subsequent malignancies in patients irradiated for testicular tumours. Br J Radiol 57: 597–602PubMedCrossRefGoogle Scholar
  118. Heimdal K, Fossa SD, Johansen A (1990) Increasing incidence and changing stage distribution of testicular carcinoma in Norway 1970–1987. Br J Cancer 62: 277–278PubMedCrossRefGoogle Scholar
  119. Hendry WF, Stedronska J, Jones CR et al. (1983) Semen analysis in testicular cancer and Hodgkin’s disease: Pre-and posttreatment findings and implications for cryopreservation. Br J Urol 55: 769–773Google Scholar
  120. Herman JG, Sturgeon J, Thomas GM (1983) Mediastinal prophylactic irradiation in seminoma. Proc Am Soc Clin Oncol 2, No 133Google Scholar
  121. Hermanek P, Sigel A (1982) Necessary extent of lymph node dissection in testicular tumours. A histopathological investigation. Eur Urol 8: 135–144Google Scholar
  122. Herr HW, Toner GC, Geller NL, Bosl GJ (1991) Patient selection for retroperitoneal lymph node dissection after chemotherapy for nonseminomatous germ cell tumors. Eur Urol 19: 1–5PubMedGoogle Scholar
  123. Hitchins RN, Newlands ES, Smith DB et al. (1989) Long-term outcome in patients with germ cell tumours treated with POMB/ACE chemotherapy: comparison of commonly used classification systems of good and poor prognosis. Br J Cancer 59: 236–242PubMedCrossRefGoogle Scholar
  124. Hochstetter AR von, Sigg C, Saremaslani P, Hedinger C (1985) The significance of giant cells in human testicular seminomas. Virchows Arch [A] 407: 309–322CrossRefGoogle Scholar
  125. Höltl W, Aharinejad S (1990) Surgical approach to the retrocrural lymph nodes. Br J Urol 66: 523–525CrossRefGoogle Scholar
  126. Hölt1 W, Kosak D, Pont J et al. (1987) Prognostic implications of vascular invasion. J Urol 137: 683–685Google Scholar
  127. Hölt1 W Gabriel C, Marberger M (1991) Asynchronous bilateral testicular tumour without previous carcinoma in situ. Eur J Cancer 27: 110PubMedGoogle Scholar
  128. Höppner D, Schnell D, Hartmann M (1991) Kann auf eine radikale RLA nach Chemotherapie beim Hodentumor verzichtet werden? Urologe [A] 30, Suppl:A 38Google Scholar
  129. Horwich A, Bell J (1991) Late mortality after radiotherapy for stage I seminoma of the testis. ECCO 6 Eur J Cancer Suppl 2:No 639Google Scholar
  130. Horwich A, Easton D, Nicholls J et al. (1987) Prognosis following chemotherapy for metastatic malignant teratoma. Br J Urol 59: 578–583PubMedCrossRefGoogle Scholar
  131. Horwich A, Brada M, Nicholls J et al. (1989) Intensive induction chemotherapy for poor risk non-seminomatous germ cell tumours. Eur J Cancer Clin Oncol 25: 177–184PubMedCrossRefGoogle Scholar
  132. Horwich A, Stenning S, Mead B et al. (1990) Prognostic factors for survival in advanced non seminomatous germ cell tumours: A study by the medical research council testicular tumour subgroup. Proc Am Soc Clin Oncol 9, No 513Google Scholar
  133. Horwich A, Dearnaley D, Mason M, AHearn R (1991 a) Single agent carboplatin for advanced seminoma. Proc Am Soc Clin Oncol 10:No 550Google Scholar
  134. Horwich A, Dearnaley DP, Nicholls J et al. (1991 b) Effectiveness of carboplatin, etoposide, and bleomycin combination chemotherapy in good prognosis metastatic testicular nonseminomatous germ cell tumors. J Clin Oncol 9: 62–69Google Scholar
  135. Hoskin P, Dilly S, Easton D, Horwich A, Hendry W, Peckham MJ (1986) Prognostic factors in stage I non-seminomatous germ-cell testicular tumors managed by orchiectomy and surveillance. Implications for adjuvant chemotherapy. J Clin Oncol 4: 1031–1036Google Scholar
  136. Huben R, Williams P, Edson A (1984) Seminoma at Roswell Park 1970 to 1979: An analysis of treatment failures. Cancer 5: 1451Google Scholar
  137. Hughes WT, Armstrong D, Bodey GP et al. (1990) Guidelines for the use of antimicrobical agents in neutropenic patients with unexplained fever. J Infect Dis 161: 381–396PubMedCrossRefGoogle Scholar
  138. Jacobsen GK, Henriksen OB, von der Maase H (1981) Carcinoma in situ of testicular tissue adjacent to malignant germ-cell tumors. Cancer 47: 2660–2662PubMedCrossRefGoogle Scholar
  139. Jacobsen GK, Norgaard Pedersen B (1986) Placental alkaline phosphatase in testicular germ cell tumours and in carcinoma-in-situ of the testis. In: Jones WG, Milford Ward A, Anderson CK (eds) Germ cell tumours II. Pergamon, Oxford, p 157Google Scholar
  140. Jaeger N (1991) Behandlung von seminomatösen and nichtseminomatösen Residualtumoren nach Chemotherapie. Onkologie 14 [Suppl 41: 12Google Scholar
  141. Jaeger N, Vahlensieck W (1991) Todesursachen beim malignen Keimzelltumor. Urologe [A] 30, Suppl:A 39Google Scholar
  142. Jaeger N, Weißbach L (1990) Indikation and Ausmaß der Salvage-Lymphadenektomie beim germinalen Hodentumor. Aktuel Urol 21: 57–63CrossRefGoogle Scholar
  143. Jaeger N, Weißbach L, Hartlapp JH, Vahlensieck W (1988) Risiko and Nutzen der Behandlung retroperitonealer teratoider „Bulky“-Tumoren. Urologe [A] 27: 283–286Google Scholar
  144. Javadpour N, Moley J (1985) Alternative to retroperitoneal lymphadenectomy with preservation of ejaculation and fertility in stage I nonseminomatous testicular cancer. Cancer 55: 1604–1606PubMedCrossRefGoogle Scholar
  145. Jewett MAS, Comisarow RH, Herman JG, Sturgeon JFG, Alison RE, Gospodarowicz MK (1984) Results with orchidectomy only for stage 1 non-seminomatous testis tumor. J Urol 131:224 AGoogle Scholar
  146. Jewett MAS, Kong Y-SP, Goldberg SD, Sturgeon JFG, Thomas GM, Alison RE, Gospodarowicz MK (1988) Retroperitoneal lymphadenectomy for testis tumor with nerve sparing for ejaculation. J Urol 139: 1220–1224PubMedGoogle Scholar
  147. Jochelson MS, Garnick MB, Balikian JP, Richie JP (1984) The efficacy of routine whole lung tomography in germ cell tumors. Cancer 54: 1007–1009PubMedCrossRefGoogle Scholar
  148. Johnson DE, Fueger JJ, Alfaro PJ, Spitz MR, Newell GR (1987) Subfertility: An etiologic factor in development of testicular cancer? Urology 30: 199–200PubMedCrossRefGoogle Scholar
  149. Johnson DH, Hainsworth JD, Kinde RE et al. (1984) Testicular function following combination chemotherapy with cisplatin, vinblastine, and bleomycin. Medical and Pediatric Oncol 12: 233–238CrossRefGoogle Scholar
  150. Johnson JO, Mattrey RF, Phillipson J (1990) Differentiation of seminomatous from nonseminomatous testicular tumors with MR imaging. AJR 154: 539–543PubMedCrossRefGoogle Scholar
  151. Jonas D, Linzback P, Weber W (1979) The use of Midodrin in the treatment of ejaculation disorders following retroperitoneal lymphadenectomy. Eur Urol 5: 184–187PubMedGoogle Scholar
  152. Kaldor JM, Day NE, Band P et al. (1987) Second malignancies following testicular cancer, ovarian cancer and Hodgkin’s disease: a international collaborative study among cancer registries. Int J Cancer 39: 571–585PubMedCrossRefGoogle Scholar
  153. Kaye S, Harding M, Stoter G et al (1989) „BOB/VIP“ — a new intensive regime for poor prognosis germ cell tumours. Proc Am Soc Clin Oncol 8:136 No 530Google Scholar
  154. Kennedy CL, Hendry WE Peckham MJ (1986) The significance of scrotal interference in stage I testicular cancer managed by orchiectomy and surveillance. Br J Urol 58: 705–708PubMedCrossRefGoogle Scholar
  155. Kießling M, Haselberg J, Struth B (1982) Fertilität und Sexualfunktion vor und nach Therapie. In: Weißbach L, Hildenbrand G (Hrsg) Register und Verbund-Studie für Hodentumoren — Bonn. Ergebnisse einer prospektiven Untersuchung. Zuckschwerdt, München, S 366–377Google Scholar
  156. Klein FA, Melamed MR, Whitmore WF (1985) Intratubular malignant germ cells ( Carci- noma in situ) accompanying invasive testicular germ cell tumors. J Urol 133: 413–415Google Scholar
  157. Kleinschmidt K, Weißbach L, Hautmann R (1991) Langzeitbeobachtung nach Strahlentherapie des kontralateralen Carcinoma in situ testis bei Patienten mit Keimzelltumoren. Onkologie 14 [Suppl 4]: 7Google Scholar
  158. Klepp O (1989) Risk indicators in stage I testicular teratoma. Lancet I1: 506PubMedCrossRefGoogle Scholar
  159. Klepp O, Olsson AM, Henrikson H et al (1990) Prognostic factors in clinical stage I nonseminomatous germ cell tumors of the testis: multivariate analysis of a prospective multicenter study. J Clin Oncol 8: 509–518PubMedGoogle Scholar
  160. Knönagel H, Bürgler W, Wüthrich R, Schulthess GK von (1988) Kernspintomographie bei Hodentumoren. Helv Chir Acta 55: 325–328PubMedGoogle Scholar
  161. Koide O, Iwai S, Baba K, Iri H (1987) Identification of testicular atypical germ cells by an immunohistochemical technique for placental alkaline phosphatase. Cancer 60: 1325–1330PubMedCrossRefGoogle Scholar
  162. Kolk M van der, Berg E van der, Mantingh A et al. (1988) Offspring of testicular cancer patients. Proc Am Soc Clin Oncol 7:No 449Google Scholar
  163. Koshida K, Wahren B (1990) Placental-like alcaline phosphatase in seminoma. Urol Res 18: 87–92PubMedCrossRefGoogle Scholar
  164. Kratzik C, Kuber W (1983) Metastasierung bei Seminom des Hodens mit besonderer Berücksichtigung des HCG-positiven Seminoms — Eine Registerauswertung. Verh Ber Dtsch Ges Urol, Springer, Berlin Heidelberg New York, S 164Google Scholar
  165. Kratzik C, Kuber W, Donner G, Lunglmayr G, Schmoller HJ (1988) Impact of sonography on diagnosis of scrotal diseases: a multicenter study. Eur Urol 14: 270–275PubMedGoogle Scholar
  166. Kratzik C, Aiginger P, Kuber W et al. (1991) Risk factors for bilateral testicular germ cell tumors. Cancer 68: 916–921PubMedCrossRefGoogle Scholar
  167. Kreuser ED, Harsch U, Hetzel WD, Schreml W (1986) Chronic gonadal toxicity in pati- ents with testicular cancer after chemotherapy. Eur J Cancer Clin Oncol 22: 289–294PubMedCrossRefGoogle Scholar
  168. Kreuser ED, Wellert M, Weidenmaier W, Egghart G, Hautmann R, Hetzel WD, Wolff H (1989 a) Praktikabilität und Relevanz der Tumorvolumetrie zur Stadienklassifikation und Remissionsbeurteilung bei Keimzelltumoren. Urologe [A] 29: 344–349Google Scholar
  169. Kreuser ED, Kurrle E, Hetzel WD et al ( 1989 b) Reversible Keimzelltoxitität nach aggressiver Chemotherapie bei Patienten mit Hodentumoren: Ergebnisse einer prospektiven Studie. Klin Wochenschr 67: 367–378Google Scholar
  170. Kröpfl D, Plewa G, Behrendt H et al. (1982) Behandlung der Aspermie nach Lymphadenektomie mit Imipramin. Akt Urol 13: 259–261CrossRefGoogle Scholar
  171. Kristianslund S, Fossa SD, Kjellevold K (1986) Bilateral malignant testicular germ cell cancer. Br J Urol 58: 60PubMedCrossRefGoogle Scholar
  172. Kuber W, Hildenbrand G, Weißbach L (1982) Maldescensus testis als Risikofaktor. In: Weißbach L, Hildenbrand G (Hrsg) Register und Verbund-Studie für Hodentumorn — Bonn. Ergebnisse einer prospektiven Untersuchung. Zuckschwerdt, München, S 349–359Google Scholar
  173. Kugelgen T von, Seidel J, Böters S, Hubmann R (1991) HLA-Typisierung bei nicht-seminomatösen Keimzelltumoren. Urologe [A] 30, Suppl:A 36Google Scholar
  174. Kührer I, Kratzik C, Wiltschke C (1991) Single agent carboplatin for stage I seminoma. Onkologie 14, Suppl 4: 23Google Scholar
  175. Lange PH, Raghavan D (1983) Clinical applications of tumor markers in testicular cancer. In: Donohue JP (ed) Testis tumors Williams, and Wilkins, Baltimore pp 111–130Google Scholar
  176. Lange HP, Nochomovitz LE, Rosai J et al. (1980) Serum alpha-feto-protein und human chorionic gonadotropin in patients with seminoma. J Urol 124: 473Google Scholar
  177. Lange PH, Narayan P, Vogelzang NJ et al (1983) Return of fertility after treatment for nonseminomatous testicular cancer: changing concepts. J Urol 129: 1131–1135PubMedGoogle Scholar
  178. Lederman GS, Herman TS, Jochelson M et al. (1989) Radiation therapy of seminoma: 17–year experience at the joint center for radiation therapy. Radiother Oncol 14: 203–208PubMedCrossRefGoogle Scholar
  179. Lester SG, Morphis JG, Hornback NB (1986) Testicular seminomas: Analysis of treatment results and failures. Int J Radiat Oncol Biol Phys 12: 353–358Google Scholar
  180. Levi F, Te VC, La Vecchia C (1990) Testicular cancer trends in the Canton of Vaud, Switzerland, 1974–1987. Br J Cancer 62: 871–873PubMedCrossRefGoogle Scholar
  181. Lewis CR, Fossa SD, Mead G et al. (1991) BOPNIP — A new platinum-intensive chemotherapy regimen for poor prognosis germ cell tumours. Ann Oncol 2: 203–211PubMedGoogle Scholar
  182. Link H, Maschmeyer G, Meyer P et al (1990) Interventional antimicrobial strategy in febrile neuropenic patients with hematologic malignancies — results of a three step randomized multicenter study. 30th Interscience Conference on Antimicrobial Agents and Chemotherapy, Atlanta, Oct. 1990Google Scholar
  183. Linkesch W, Krainer M, Wagner A (1991) Ultra-high carboplatin, VP-16, cyclophosphamide with ABMT in refractory or relapsed non-seminomatous germ cell tumours. Onkologie 14 [Suppl 41: 30Google Scholar
  184. Lippert MC, Javadpour N (1981) Lactic dehydrogenase in the monitoring and prognosis of testicular cancer. Cancer 48: 2274–2278PubMedCrossRefGoogle Scholar
  185. Loehrer PJ (1991) Salvage therapy and autologous bone marrow transplantation. In: Horwich A (ed) Testicular cancer; investigation and management. Chapman, and Hall Medical, London, pp 257–266Google Scholar
  186. Loehrer PJ, Hui S, Clark S et al. (1986) Teratoma following cisplatin-based combination chemotherapy for nonseminomatous germ cell tumors: A clinicopathological correlation. J Urol 135: 1183–1189Google Scholar
  187. Loehrer PJ, Birch R, Williams SD et al. (1987) Chemotherapy of metastatic seminoma: the Southeastern Cancer Study Group experience. J Clin Oncol 5: 1212–1220PubMedGoogle Scholar
  188. Loehrer PJ, Elson P, Johnson DH, Williams SD, Trump DL, Einhorn LH (1991) A randomized trial of cisplatin plus etoposide with or without bleomycin in favorable prognosis disseminated germ cell tumors: an ECOG study. Proc Am Soc Clin Oncol 10:No 540Google Scholar
  189. Logothetis CJ, Samuels ML, Selig DE et al. (1986) Cyclic chemotherapy with cyclophosphamide, doxorubicin, and cisplatin plus vinblastine and bleomycin in advanced germinal tumors. Am J Med 81: 219–228PubMedCrossRefGoogle Scholar
  190. Logothetis CJ, Swanson DA, Dexeus F et al. (1987) Primary chemotherapy of clinical stage II nonseminomatous germ cell tumors of the testis: a follow-up of 50 patients. J Clin Oncol 5: 906–911PubMedGoogle Scholar
  191. Lorigan JG, Eftekhari F, David CL, Shirkhoda A (1988) The growing teratoma syndrome: an unusual manifestation of treated, nonseminomatous germ cell tumors of the testis. AJR 151: 325–329PubMedCrossRefGoogle Scholar
  192. Lynch JH, Maxted WC (1983) Use of ephedrine in post-lymphadenectomy ejaculatory failure: A case report. J Urol 229: 379Google Scholar
  193. Maase H von der, Giwercman A, Müller J, Skakkebaek NE (1987) Management of carcinoma-in-situ of the testis. In: Rorth M, Daugaard G, Skakkebaek NE, Grigor KM, Giwercman A (eds) Carcinoma in situ and cancer of the testis. Blackwell Scientific, Oxford, p 209Google Scholar
  194. Maase H von der, Meinecke B, Skakkebaek NE (1988) Residual carcinoma-in-situ of contralateral testis after chemotherapy. Lancet 1I: 477–478Google Scholar
  195. Maatman I, Bukowski RM, Montie JE (1984) Retroperitoneal malignancies several years after initial treatment of germ cell cancer of the testis. Cancer 54: 1962–1965PubMedCrossRefGoogle Scholar
  196. Mann K (1984) Humanes choriogonadotropin (hCG). In: Thomas L (Hrsg) Labor and Diagnose, 2. Aufl. Med Verlagsges. Marburg, S 680–687Google Scholar
  197. Mann K, Siddle K (1988) Evidence for free beta-subunit secretion in so-called human chorionic gonadotropin-positive seminoma. Cancer 62: 2378PubMedCrossRefGoogle Scholar
  198. Martin RH, Hildebrand K, Yamamoto J et al. (1986) An increased frequency of human sperm chromosomal abnormalities after radiotherapy. Mutation Res. 174: 219–225PubMedCrossRefGoogle Scholar
  199. Mason BR, Kearsley JH (1988) Radiotherapy for stage 2 testicular seminoma: The prognostic influence of tumor bulk. J Clin Oncol 6: 1856–1862Google Scholar
  200. McLeod DG, Weiss RB, Stablein DM et al. (1991) Staging relationships and outcome in early stage testicular cancer: a report from the testicular cancer intergroup study. J Urol 145: 1178–1183PubMedGoogle Scholar
  201. Medical Research Council Working Party on Testicular Tumours (1985) Prognostic factors in advanced non-seminomatous germ-cell testicular tumours. Lancet II: 8–11Google Scholar
  202. Mirimanoff RO, Shipley WU, Dosoretz DE, Meyer JE (1985) Pure seminoma of the testis: the results of radiation therapy in patients with elevated human chorionic gonadotropin titers. J Urol 134: 1124–1126PubMedGoogle Scholar
  203. Morgan DAL, Caillaud JM, Bellet D, Eschwege F (1982) Gonadotropin producing seminoma: a distinct category of germ cell neoplasm. Clin Radiol 33: 149PubMedCrossRefGoogle Scholar
  204. Moss AR, Osmond D, Baccetti P, Torti FM, Gurgin V (1986) Hormonal risk factors in testicular cancer. A case control study. Am J Epidemiôl 124: 39–52Google Scholar
  205. Mostofi FK (1977) Epidemiology and pathology of tumors of human testis. Recent Results Cancer Res 60: 176–195PubMedCrossRefGoogle Scholar
  206. Mostofi FK (1980) Pathology of germ cell tumors of testis. Cancer 45: 1735–1754PubMedGoogle Scholar
  207. Mostofi FK, Sobin LH (1977) Histological typing of testis tumours. International Histological Classification of Tumours, no 16. WHO, GenfGoogle Scholar
  208. Motzer RJ, Bosl G, Heelan R (1987) Residual mass: an indication for further therapy in patients with advanced seminoma following systemic chemotherapy. J Clin Oncol 5: 1064–1070PubMedGoogle Scholar
  209. Motzer RJ, Gulati SC, Crown J, Bajorin DF, Pfister D, Weisen SF, Bosl GJ (1991) High dose carboplatin + etoposide with autologous bone marrow rescue in poor risk nonseminomatous germ cell tumor patients with slow serum tumor marker decline during induction with cyclophosphamide, bleomycin, actinomycin D, vinblastine, cisplatin (VAB-6). Proc Am Soc Clin Oncol 10:No 518Google Scholar
  210. Mumperow E, Hartmann M (1992) Spermatic cord a-human chorionic gonadotropin levels in geminoma and their clinical implications. J. Urol 147: 1041–1043PubMedGoogle Scholar
  211. Mumperow E, Lauke H, Hartmann M (1990) Das Carcinoma in situ des Hodens beim Hodentumor — Häufigkeit and Treffsicherheit der Screening-Biopsie. Urologe [B] 30:A 36Google Scholar
  212. Narayan P, Lange PH, Fraley EE (1982) Ejaculation and fertility after extended retroperitoneal lymph node dissection for testicular cancer. J Urol 127: 658–688Google Scholar
  213. Newbold RR, Bullock BC, McLachlan JA (1987) Testicular tumors in mice exposed in utero to diethylstilbestrol. J Urol 138: 1446–1450PubMedGoogle Scholar
  214. Nielsen OS, Munro AJ, Duncan W et al. (1990) Is placental alkaline phosphatase (PLAP) a useful marker for seminoma? Eur J Cancer 26: 1049–1054PubMedCrossRefGoogle Scholar
  215. Nijman JM (1987) Some aspects of sexual and gonadal function in patients with a nonseminomatous germ-cell tumor of the testis. Dissertation GroningenGoogle Scholar
  216. Oliver RTD (1986) Fertility of patients with germ cell tumors of the testis before and after treatment with platinum and etoposide containing combination chemotherapy regimes. In: Jones WG, Milford Ward A, Anderson CK (eds): Germ cell tumours II, Pergamon, Oxford, p 467–470Google Scholar
  217. Oliver RTD (1989) Alternatives to radiotherapy in patients with seminoma. Proc ECCO 5:No P-0836Google Scholar
  218. Oliver RTD, Read G, Jones WG, Williams CJH, Peckham MJ (1984) Justification for a policy of surveillance in the management of stage I testicular teratoma. In: Denis L, Murphy GP, Schröder F (eds) Controlled clinical trials in urologic oncology. Raven, New York, p 73Google Scholar
  219. Orecklin JR, Kaufmann JJ, Thompson RW (1973) Fertility in patients treated for malignant testicular tumors. J Urol 109: 293–295PubMedGoogle Scholar
  220. Osterlind A (1986) Diverging trends in incidence and mortality of testicular cancer in Denmark, 1943–1982. Br J Cancer 53: 501PubMedCrossRefGoogle Scholar
  221. Ozols RF, Ihde DC, Linehan WM, Jacob J, Ostchega Y, Young RC (1988) A randomized trial of standard chemotherapy vs a high-dose chemotherapy regimen in the treatment of poor prognosis nonseminomatous germ cell tumors. J Clin Oncol 6: 1031–1040PubMedGoogle Scholar
  222. Panicek DM, Toner GC, Heelan RT, Bosl GJ (1990) Nonseminomatous germ cell tumors: enlarging masses despite chemotherapy. Radiology 175: 499–502PubMedGoogle Scholar
  223. Peckham MJ, Brada M (1987) Surveillance following orchidectomy for stage I testicular cancer. Int J Androl 10: 247PubMedCrossRefGoogle Scholar
  224. Peckham MJ, Barret A, Liew KH et al. (1983) The treatment of metastatic germ cell testicular tumors with bleomycin, etoposide and cisplatin. Br J Cancer 47: 613–619PubMedCrossRefGoogle Scholar
  225. Peckham MJ, Hendry WF (1985) Clinical stage II non-seminomatous germ cell testicular tumors. Results of management by primary chemotherapy. Br J Urol 57: 763–768Google Scholar
  226. Peckham MJ, Horwich A, Hendry WF (1986) Surveillance following orchiectomy for clinical stage I testicular germ cell malignancy. In: Jones WG, Ward AM, Anderson CK (eds) Germ cell tumours. II. Pergamon, Oxford, p 441–449Google Scholar
  227. Peckham MJ, Freedman LS, Jones WG et al (1988) Der Einfluß der Histopathologie auf die Rezidivwahrscheinlichkeit bei Patienten mit nichtseminomatösen Hodenkarzinomen im Stadium I nach alleiniger Orchiektomie. In: Schmoll HJ, Weißbach L (Hrsg) Diagnostik und Therapie von Hodentumoren. Springer, Berlin Heidelberg New York Tokyo, S 152–160Google Scholar
  228. Percarpio B, Clements JC, McLeod DG, Sorgen SD, Cardinale FS (1979) Anaplastic seminoma. An analysis of 77 patients. Cancer 43: 2510–2513PubMedCrossRefGoogle Scholar
  229. Pfannmüller E, Bruggmoser G, Siems H, Wannenmacher M (1986) Reduction of gonadal dose to preserve fertility in patients treated for seminoma testis. Proc 18. Natl Cancer Congress of the German Cancer Soc, No Uro 21: 143Google Scholar
  230. Pfannmüller-Schurr EL, Hodapp N, Bruggmoser G, Wannenmacher M (1988) Strahlentherapie der Seminome im Stadium IIA/B. In: Schmoll HJ, Weißbach L (Hrsg) Diagnostik und Therapie von Hodentumoren. Springer, Berlin Heidelberg New York Tokyo, S 409–414Google Scholar
  231. Pflüger KH, Mack J, Ulshöfer B, Keitz A von, Havemann K, Rodeck G (1988) Primäre Chemotherapie und elektive Operation bei Patienten mit nichtseminomatösen Hodenkarzinomen. In: Schmoll HJ, Weißbach L (Hrsg) Diagnostik und Therapie von Hodentumoren. Springer Berlin Heidelberg New York Tokyo, S 186–191Google Scholar
  232. Pizzocaro G (1985) Unilateral lymphadenectomy in preoperative clinically negative non-seminoma. In: Khoury S, Küss R, Murphy GP, Chatelain C, Karr JP (eds) Testicular cancer. Liss, New York, p 563Google Scholar
  233. Pizzocaro G (1987) Retroperitoneal lymph node dissection in clinical stage IIA und IIB nonseminomatous germ cell tumours of the testis. Int J Androl 10: 269–275PubMedCrossRefGoogle Scholar
  234. Pizzocaro G, Salvioni R, Pasi M, Zanoni F, Milani A, Pilotti S, Monfardini S (1985) Early resection of residual tumor during cisplatin, vinblastine, bleomycin combination chemotherapy in stage III and bulky stage II nonseminomatous testicular cancer. Cancer 56: 249–255PubMedCrossRefGoogle Scholar
  235. Pizzocaro G, Salvioni R, Piva L, Zanoni F, Milani A, Faustini M (1986) Cisplatin combination chemotherapy in advanced seminoma. Cancer 58: 1625–1629PubMedCrossRefGoogle Scholar
  236. Pizzocaro G, Zanoni F, Salvioni R, Milani A, Piva L, Pilotti S (1987) Difficulties of a surveillance study omitting retroperitoneal lymphadenectomy in clinical stage I nonseminomatous germ cell tumors of the testis. J Urol 138: 1393PubMedGoogle Scholar
  237. Pont J, Höltl W, Kosak D, Machacek E, Kienzer H, Julcher H, Honetz N (1990) Risk-adapted treatment choice in stage I nonseminomatous testicular germ cell cancer by regarding vascular invasion in the primary tumor: a prospective trial. J Clin Oncol 8: 16–20PubMedGoogle Scholar
  238. Pont J, Höltl W, Machacek E, Kosak D (1991) Orchiectomy plus chemotherapy: an option for stage I nonseminomatous testicular cancer with high risk? Onkologie 14 [Suppl 4]: 14Google Scholar
  239. Pottern LM, Goedert JJ (1986) Epidemiology of testicular cancer. In: Javadpour N (ed) Principles and management of testicular cancer. Thieme, New York, pp 108–119Google Scholar
  240. Porst H, Altwein JE, Mayer R, Bach D (1984) Erektions-und Ejakulationsstörungen nach retroperitonealer Lymphadenektomie beim nichtseminomatösen Hodentumor. Urologe A 23: 324–328PubMedGoogle Scholar
  241. Raghavan D, Peckham MJ, Heyderman E et al. (1982) Prognostic factors in clinical stage I non-seminomatous germ-cell tumours of the testis. Br J Cancer 45: 167–173PubMedCrossRefGoogle Scholar
  242. Raghavan D, Coils B, Levi F et al. (1988) Surveillance for stage I non-seminomatous germ cell tumours of the testis: the optimal protocol has not yet been defined. Br J Urol 61: 522PubMedCrossRefGoogle Scholar
  243. Ray B, Hadju SI, Whitmore WF Jr (1974) Distribution of retroperitoneal lymph node metastases in testicular germinal tumors. Cancer 33: 340–348PubMedCrossRefGoogle Scholar
  244. Read G, Johnson RJ, Wilkinson PM, Eddleston (1983) Prospective study of follow-up alone in stage I teratoma of the testis. Br Med J 287: 1503Google Scholar
  245. Reno DR (1988) Men’s knowledge and health beliefs about testicular cancer and testicular self-examination. Cancer Nurs 11: 112–117PubMedCrossRefGoogle Scholar
  246. Richie JP (1988) Modified retroperitoneal lymphadenectomy for patients with clinical stage I testicular cancer. Semin Urol 6: 216–222PubMedGoogle Scholar
  247. Rodenburg CJ, Stoter G (1991) Alternating regimes to overcome drug resistance in poor risk germ cell tumour patients. In: Horwich A (ed) Testicular cancer; investigation and management. Chapman, and Hall Medical, London, pp 249–255Google Scholar
  248. Rorth M (1991) Dose escalation of cisplatin in the chemotherapy of poor risk germ cell tumour patients. In: Horwich A (ed) Testicular cancer; investigation and management. Chapman, and Hall Medical, London, pp 221–231Google Scholar
  249. Rorth M, Maase H von der, Sandberg Nielsen E, Schulz H, Pedersen M (1985) Treatment of non-seminomatous testicular germ cell tumors in Denmark since 1979. In: Khoury S, Kiiss R, Murphy GP, Chatelain C, Karr JP (eds) Testicular cancer. Liss, New York, pp 539–551Google Scholar
  250. Rorth M, Maase H von der, Nielsen ES, Pedersen M, Schultz H (1987) Orchidectomy alone versus orchidectomy plus radiotherapy in stage I nonseminomatous testicular cancer: a randomized study by the Danish Testicular Carcinoma Study Group. Int J Androl 10: 255PubMedCrossRefGoogle Scholar
  251. Rorth M, Krag Jacobsen GH, Lindegaard Madsen E et al. for the DATECA Study Group (1990) Prediction of relapse in stage I non-seminomatous testicular cancer. Proc Am Soc Clin Oncol: Abstract No 509Google Scholar
  252. Roth A, Le Pelletier O, Cukier J (1983) Cryptocarcinome tropho-blastique à cellules mononuclées sécrétrices d’hormones gonadotrophiques chorioniques bèta dans les séminomes. Presse Med 44: 2801–2804Google Scholar
  253. Rubery ED (1983) Return of fertility after curative chemotherapy for disseminated teratoma of testis. Lancet 1I: 186PubMedCrossRefGoogle Scholar
  254. Rustin GJS, Pektasides D, Bagshawe KD, Newlands ES, Begent RHJ (1987) Fertility after chemotherapy for male and female germ cell tumours. In: Rorth M, Daugaard G, Skakkebaek NE, Grigor KM, Giwercman A (eds): Carcinoma in situ and cancer of the testis. Blackwell, Oxford, pp 389–392Google Scholar
  255. Sagerman RH, Kotlove DJ et al. (1989) Stage II seminoma: Results of postorchiectomy irradiation. Radiology 172: 565–568Google Scholar
  256. Salvioni R et al. (1987) Management of far advanced germ-cell tumors of the testis. Proc Eur Conference Clin Oncol 4: 184Google Scholar
  257. Samuels M, Logothetis C (1983) Follow-up study of sequential weekly pulse-dose cisplatinum for far-advanced seminoma. Proc Am Soc Clin Oncol 2:137, C-535Google Scholar
  258. Sandemann TF (1966) The effects of X-irradiation on male human fertility. Br J Radiol 39: 901–907CrossRefGoogle Scholar
  259. Schaner EG, Chang AE, Doppman JL, Conkle DM, Flye MW, Rosenberg SA (1978) Comparison of computed and conventional whole lung tomography in detecting pulmonary nodules: a prospective radiologic-pathologic study. AJR 131: 51PubMedCrossRefGoogle Scholar
  260. Scheulen ME, Niederle N, Pfeiffer R, Schmidt CG (1988) Prognostische Faktoren bei Patienten mit fortgeschrittenen nicht-seminomatösen Hoden-Karzinomen. In: Scholl HJ, Weißbach L (Hrsg) Diagnostik und Therapie von Hodentumoren. Springer, Berlin Heidelberg New York Tokyo, S 96–110Google Scholar
  261. Schlappack OK, Kratzik C, Schmidt W, Spona J (1988) Spermiogenese nach Strahlentherapie wegen Seminoms. In: Schmoll HJ, Weißbach L (Hrsg) Diagnostik und Therapie von Hodentumoren. Springer, Berlin Heidelberg New York Tokyo, S 493–500Google Scholar
  262. Schmitt G, Sauerwein W, Bamberg M (1980) La Radiotherapie des Seminomes; Resultats du Centre universitaire de Radiotherapie de Essen. J Eur Radiother 1: 37–41Google Scholar
  263. Schmoll HJ (1984) Aktuelle Aspekte zur Seminomtherapie. Onkologisches Forum 3: 11–16Google Scholar
  264. Schmoll HJ, Schubert I, Arnold H et al. (1987) Disseminated testicular cancer with bulky disease:’ results of a phase-II study with cisplatin ultra high dose/VP-16/bleomycin. Int J Androl 10: 311–317PubMedCrossRefGoogle Scholar
  265. Schmoll HJ et al. (1989) An intensive five drug regimen,PEBOI’ in patients with far advanced testicular cancer. Proc Am Soc Clin Oncol 8: 149Google Scholar
  266. Schöffski P, Bokemeyer C, Harstrick A, Schmoll HJ (1991) Ätiologie und Epidemiologie von Keimzelltumoren. Onkologie 14 [Suppl 4]: 1CrossRefGoogle Scholar
  267. Schuette J, Niederle N, Scheulen ME et al. (1985) Chemotherapy of metastatic seminoma. Br J Cancer 51: 467–472PubMedCrossRefGoogle Scholar
  268. Schultz HP, Arends J, Barblebo H et al. (1984) Testicular carcinoma in Denmark 1976–1980. Stage and selected clinical parameters at presentation. Acta Radiol Oncol 23: 249–253Google Scholar
  269. Senturia YD (1987) The epidemiology of testicular cancer. Br J Urol 60: 285–291PubMedCrossRefGoogle Scholar
  270. Senturia YD, Peckham CS, Peckham MJ (1985) Children fathered by men treated for testicular cancer. Lancet 11: 766–769CrossRefGoogle Scholar
  271. Seppelt U (1988) Validierung verschiedener diagnostischer Methoden zur Beurteilung des Lymphknotenstatus. In: Weißbach L, Bussar-Maatz R (Hrsg) Die Diagnostik des Hodentumors und seine Metastasen. Karger, Basel, S. 154–169Google Scholar
  272. Shipley WU (1980) The role of radiation therapy in the management of adult germinal testis tumors. In: Einhorn LH (ed) Testicular tumors — management and treatment. S 47–67Google Scholar
  273. Siegert W, Beyer J, Weissbach V et al. (1991) Treatment of relapsed or refractory germ cell tumors with high dose chemotherapy and autologous stem cell rescue. Onkologie 14 [Suppl 41: 30Google Scholar
  274. Sigg C, Hedinger C (1981) Atypical germ cells in testicular biopsy in male sterility. Int J Androl [Suppl 4]: 163–171Google Scholar
  275. Skakkebaek NE (1972) Possible carcinoma-in-situ of the testis. Lancet 1I: 516CrossRefGoogle Scholar
  276. Skakkebaek NE, Berthelsen JG, Müller J (1982) Carcinoma-in-situ of the undescended testis. Urol Clin N Am 9: 377–385Google Scholar
  277. Sledge GW Jr, Eble JN, Roth BJ, Wuhrman BP, Fineberg N, Einhorn LH (1988) Relation of proliferative activity to survival in patients with advanced germ cell cancer. Cancer Res 48: 3864–3868PubMedGoogle Scholar
  278. Smithers DW, Wallace DM, Austin DE (1973) Fertility after unilateral orchidectomy and radiotherapy for patients with malignant tumours of the testis. Br Med J IV77–79Google Scholar
  279. Socinski MA, Garnick MB, Stomper PC, Fung CY, Richie JP (1988) Stage II nonseminomatous germ cell tumors of the testis: an analysis of treatment options in patients with low volume retroperitoneal disease. J Urol 140: 1437–1441PubMedGoogle Scholar
  280. Sogani PC, Whitmore WF Jr, Herr HW et al. (1984) Orchiectomy alone in the treatment of clinical stage I nonseminomatous germ cell tumor of the testis. J Clin Oncol 2: 267–270PubMedGoogle Scholar
  281. Sogani PC, Whitmore WF, Herr HW, Morse MJ, Bosl G, Fair W (1985) Long term experience with orchiectomy alone in treatment of clinical stage I nonseminomatous germ cell tumor of testis. J Urol 133: 246AGoogle Scholar
  282. Sogani PC, Fair WR (1988) Surveillance alone in the treatment of clinical stage I nonseminomatous germ cell tumor of the testis ( NSGCT ). Semin Urol 6: 53–56Google Scholar
  283. Sommerhoff CH (1982) Altersverteilung. In: Weißbach L, Hildenbrand G (Hrsg) (1991) Register und Verbund-Studie für Hodentumoren —Bonn. Ergebnisse einer prospektiven Untersuchung. Zuckschwerdt, München, S 209–214Google Scholar
  284. Specht L, Maase H von der, Jacobsen GK and the DATECA Study Group (1991) Prognostic factors for relapse in seminoma stage I treated with orchiectomy alone. ECCO 6 EJC [Suppl 2]:No 636Google Scholar
  285. Splinter TAW, Keijzer W, Mulder MP (1987) Activation of RAS oncogenes in seminoma (Abstract No 679). Proc ECCO 4: 179Google Scholar
  286. Staubitz WJ, Early KS, Magoss IV Murphy GP (1973) Surgical treatment of non-seminomatous germinal testis tumors. Cancer 32: 1206–1211PubMedCrossRefGoogle Scholar
  287. Stanton GF, Bosl GJ, Whitmore WF er al. (1985) VAB-6 as initial treatment of patients with advanced seminoma. J Clin Oncol 3: 336–339PubMedGoogle Scholar
  288. Stomper PC, Fung CY, Socinsky MA, Garnick MB, Richie JP (1987) Detection of retro-peritoneal metastases in early-stage nonseminomatous testicular cancer analysis of different CT criteria. AJR 149: 1187–1190PubMedCrossRefGoogle Scholar
  289. Stoter G, Sylvester R, Sleijfer DT et al. (1987 a) Multivariate analysis of prognostic factors in patients with disseminated nonseminomatous testicular cancer: results from a European Organization for Research on Treatment of Cancer Multiinstitutional Phase III Study. Cancer Res 47: 2714–2718Google Scholar
  290. Stoter G, Kaye S, Jones W et al. ( 1987 b) Cisplatin and VP 16 +/- Bleomycin ( BEP vs EP) in good risk patients with disseminated non-seminomatous testicular cancer; results of a randomized EORTCGU group study. Proc ECCO P 179:No 681Google Scholar
  291. Stoter G, Sylvester R, Sleijfer DT et al. (1988) A multivariate analysis of prognostic factors in disseminated non-seminomatous testicular cancer. Prog Clin Biol Res 269: 381–393PubMedGoogle Scholar
  292. Stoter G, Bosl GJ, Droz JP et al. (1990) Prognostic factors in metastatic germ cell tumours. In: Newling DW, Jones WG (eds). Prostate cancer and testicular cancer. Wiley-Liss, New York, pp 313–319Google Scholar
  293. Strohmeyer T, Hartmann M (1984) Doppelseitige Hodentumoren: Fallpräsentation und Therapiekonzept. Aktuel Urol 15: 186Google Scholar
  294. Stuart NSA, Woodroffe CM, Grundy R, Cullen MH (1990) Long-term toxicity of chemotherapy for testicular cancer — the cost of cure. Br J Cancer 61: 479–484PubMedCrossRefGoogle Scholar
  295. Swerdlow AJ, Huttly SRA, Smith PG (1989) Testis cancer: postnatal hormonal factors, sexual behaviour and fertility. Int J Cancer 43: 549–553PubMedCrossRefGoogle Scholar
  296. Terebelo HR, Taylor HG, Brown A et al. (1983) Late relapse of testicular cancer. J Clin Oncol 1: 566–571PubMedGoogle Scholar
  297. Thomas GM (1985) Controversies in the management of testicular seminoma. Cancer 55: 2296–2302PubMedCrossRefGoogle Scholar
  298. Thomas GM (1991) Surveillance for stage I seminoma. Onkologie 14 [Suppl 41: 21Google Scholar
  299. Thomas GM, Jewett MA, Duncan WD, Sturgeon JF, Alison RE, Goldberg SD, Gospodarowicz MK (1989) Surveillance of stage I seminoma post orchidectomy. J Urol 142: 313–316PubMedGoogle Scholar
  300. Thomas G, Rider W, Dembo A et al. (1982) Seminoma of the testis: Results of treatment and patterns of failure after radiation therapy. Int J Radiat Oncol Biol Phys 8: 165–174Google Scholar
  301. Thomas PRM, Mansfield MD, Hendry WF et al. (1977) The implications of scrotal interference for the preservation of spermatogenesis in the management of testicular tumours. Br J Surg 64: 352–354PubMedCrossRefGoogle Scholar
  302. Thompson PI, Harvey VJ (1987) Disease relapse in patients with stage I non-seminomatous germ cell tumour of testis on active surveillance. Proc ECCO 4: 183Google Scholar
  303. Thon WF, Sparwasser C, Gilbert P, Altwein JE (1987) Stellenwert der Surveillance-Therapie beim nichtseminomatösen Hodentumor im klinischen Stadium I. Urol Int 42: 445PubMedCrossRefGoogle Scholar
  304. Thornhill JA, Fennelly JJ, Kelly DG, Walsh A, Fitzpatrick JM (1987) Patient’s delay in the presentation of testis cancer in Ireland. Br J Urol 59: 447–451PubMedCrossRefGoogle Scholar
  305. Thurnher S, Hricak H, Carroll PR, Pobiel RS, Filly RA (1988) Imaging the testis: comparison between MR imaging and US. Radiology 167: 631–636PubMedGoogle Scholar
  306. Tonkin KS, Rustin GJS, Wignall B, Paradinas F, Bennett M (1989) Successful treatment of patients in whom germ cell tumour masses enlarged on chemotherapy while their serum tumour markers decreased. Eur J Cancer Clin Oncol 25: 1739–1743PubMedCrossRefGoogle Scholar
  307. UICC (1987) TNM Classification of malignant tumours. Hermanek P, Sobin HL (eds) International Union Against Cancer, GenevaGoogle Scholar
  308. Vahlensieck W (1968) „Erweiterte Semikastration“, Lymphadenektomie und „erweiterte Lymphadenektomie”, Radiotherapie und zytostatische „Triple-drug-Intervalltherapie“ bei germinalen Hodentumoren. Z Urol 61:537–552Google Scholar
  309. Vogeizang NJ (1991) The acute and chronic toxicities of chemotherapy for metastatic testicular cancer. In: Horwich A (ed). Testicular cancer; investigation and management. Chapman, and Hall Medical, London, pp 331–351Google Scholar
  310. Vugrin D, Whitmore WF, Batata M (1981) Chemotherapy of disseminated seminoma with combination of Cisdiaminedichloroplatinum (II) and cyclophosphamide. Cancer Clin Trials 4: 423–427PubMedGoogle Scholar
  311. Walz PH, Eitner S, Tan HK, Böhm E (1990) Auftreten und Ausbreitung von Carcinoma in situ und intratubulärer Keimzellenneoplasie bei tumorbefallenen Hoden. Urologe [B] 30: A37Google Scholar
  312. Wannenmacher M, Pfannmüller-Schurr EL, Bruggmoser G (1988) Adjuvante Strahlentherapie der Seminome im Stadium I. In: Schmoll HJ, Weißbach L (Hrsg) Diagnostik und Therapie von Hodentumoren. Springer, Berlin Heidelberg New York Tokyo, S 152–160Google Scholar
  313. Warhol M, Nickoloff B, Weinberg D (1983) Seminoma metastasis to the terminal ileum after a 17–year disease-free interval. Cancer 52: 1957–1958PubMedCrossRefGoogle Scholar
  314. Weißbach L, Bode HU (1982) Die modifizierte Lymphadenektomie zur Protektion der Ejakulation. In: Illiger HJ, Sack H, Seeber S, Weißbach L, (Hrsg) Nicht seminomatöse Hodentumoren. Karger, Basel (Beiträge zur Onkologie 8, S 133–138 )Google Scholar
  315. Weißbach L, Bussar-Maatz R (1988) Operative Maßnahmen beim Hodentumor. Onkolog Forum 3: 19–28Google Scholar
  316. Weißbach L, Bussar-Maatz R (1991) Das HCG-positive Seminom — Ergebnisse der deutschen Studie. Onkologie 14 [Suppl 41: 20Google Scholar
  317. Weißbach L, Hartlapp JH (1991) Adjuvant chemotherapy of metastatic stage II nonseminomatous testis tumor. J Urol 146: 1295–1298PubMedGoogle Scholar
  318. Weißbach L, Hildenbrand G (1984) Register und Verbundstudie für Hodentumoren. Ein Ergebnisbericht nach sieben Jahren. Z Allg Med 60: 156–163Google Scholar
  319. Weißbach L, Widmann T (1986) Familial tumor of the testis. Eur Urol 12:104–108 Weißbach L, Sommerhoff C, Struth B (1980) Aussagen zur Fertilität bei Patienten mit germinalen Hodentumoren. Extracta Urologica 3: 159–174Google Scholar
  320. Weißbach L, Boedefeld EA for the Testicular Tumor Study Group (1987) Localization of solitary and multiple metastases in stage II nonseminomatous testis tumor as basis for a modified staging lymph node dissection in stage I. J Urol 138: 77–82Google Scholar
  321. Weißbach L, Boedefeld EA, Horstmann-Dubral B (1990) Surgical treatment of stage-I non-seminomatous germ cell testis tumor. Eur Urol 17: 97–106PubMedGoogle Scholar
  322. Wettlaufer JN, Feiner AS, Robinson WA (1984) Vincristine, cisplatin and bleomycin with surgery in the management of advanced metastatic nonseminomatous testis tumors. Cancer 53: 203–209PubMedCrossRefGoogle Scholar
  323. Willan B, McGowan G (1985) Seminoma of the testis: A 22–year experience with radiation therapy. Int J Radiat Oncol Biol Phys 11: 1769–1775PubMedCrossRefGoogle Scholar
  324. Williams SD, Stablein DM, Einhorn LH et al. (1987a) Immediate adjuvant chemotherapy versus observation with treatment at relapse in pathological stage II testicular cancer. N Engl J Med 317: 1433–1488PubMedCrossRefGoogle Scholar
  325. Williams SD, Birch R, Einhorn LH, Irwin L, Greco F, Loehrer PJ (1987b) Treatment of disseminated germ cell tumors with cisplatin, bleomycin, and either vinblastine or etoposide. N Engl J Med 316: 1435–1440PubMedCrossRefGoogle Scholar
  326. Wishnow KI, Dunphy CH, Johnson DE et al. (1989) Identifying patients with low-risk clinical stage I nonseminomatous testicular tumors who should be treated by surveillance. Urology 34: 339–343PubMedCrossRefGoogle Scholar
  327. Zagars GK, Babaian RJ (1987) Stage I testicular seminoma rationale for postorchiectomy radiation therapy. Int J Radiat Oncol Biol Phys 13: 155–162.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1994

Authors and Affiliations

  • L. Weißbach
  • R. Bussar-Maatz

There are no affiliations available

Personalised recommendations